Patients with chronic obstructive pulmonary disease (COPD) who were classified as frail were more likely to have lower quality of life, increased rate and length of hospitalization, and a higher rate of mortality compared with non-frail patients, according to the results of a study published in the Annals of the American Thoracic Society .
Researchers from the University of Oxford in the United Kingdom found that a pleural adherence score derived from thoracic ultrasound (TUS) at 24 hours post-talc administration is predictive of long-term pleurodesis success in patients with symptomatic malignant pleural effusion (MPE). Findings were published in CHEST.
The prevalence of overlap syndrome in obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) in Medicare beneficiaries increased 4-fold from 2004 to 2013, according to a study published in Annals of the American Thoracic Society.
Penn Highlands Healthcare is the first medical facility in the region to offer bronchoscopic lung volume reduction using the first lung valve approved by the U.S. Food and Drug Administration for helping emphysema patients breathe easier without major surgery.
A cluster-randomized clinical trial of low tidal volume ventilation vs usual care in patients with acute respiratory failure found the treatment to be unfeasible, according to a prospective assessment published in the Annals of the American Thoracic Society.
The criteria physicians use to diagnose asthma are not uniform and often do not follow official guidelines, according to study results published in the Annals of the American Thoracic Society. These results mirror previous findings.
A new, lower profile device appears to be safe and effective for resuscitative endovascular balloon occlusion of the aorta (REBOA) in patients with blunt trauma, researchers report.
REBOA has been used for decades to control various types of hemorrhage below the diaphragm. The earliest experience with REBOA involved long platform guidewires and large introducer sheaths (12 Fr), but in 2015 a smaller profile device with a 7 Fr introducer sheath and no platform guidewire was approved.
According to the National Cancer Institute, patients diagnosed with non-small cell lung cancer (NSCLC) between the years 1995 and 2001 had 15 percent chance of being alive 5 years later. For patients with stage IV disease, describing cancer that has spread to distant sites beyond the original tumor, that statistic drops to 2 percent. Now to University of Colorado Cancer Center study published in the Journal of Thoracic Oncology tells a much more optimistic story.
New clinical practice guidelines for the management of malignant pleural effusions were published in the January issue of the Annals of the American Thoracic Society.
Living in India and inhaling lungful of polluted air every day is like being a chronic smoker according to a recent report by India’s State-Level Disease Burden Initiative. This partly explains why many people in urban India have a persistent dry and hacking cough even if they don’t have asthma or have never smoked.
Microbiome diversity in cystic fibrosis (CF) patients' lower respiratory tract prediction progression to early end-stage lung disease (eESLD) and faster lung-function decline, according to new research .
A 40-mg dose of slow-release morphine may be safe for non-severely obese patients with obstructive sleep apnea (OSA), researchers in Australia report. "Slow-release morphine did not seem to be the OSA of the men in our study." For most of the men, there were no differences in breathing during sleep whether they received oral 40-mg slow-release morphine or placebo, "said Dr. David Wang.